Given Imaging’s PillCam Colon 2 Strategy Shift Will Delay Screening Claim

Firm initially will pursue diagnostic imaging claim for its PillCam Colon 2 video capsule, rather than a screening claim, as the fastest route to U.S. market. The strategy shift follows preliminary clinical trial data review.